Overview of genetic syndromes associated with adrenocortical cancer

Adrenocortical Carcinoma: Basic Science and Clinical Concepts

Volumn , Issue , 2011, Pages 153-172

  Else, Tobias ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84865208747     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-77236-3_10     Document Type: Chapter

References (80)

1. Bilimoria KY (2008) Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors. Cancer 113(11):3130-3136
2. Agarwal SK (2004) Molecular pathology of the MEN1 gene. Ann N Y Acad Sci 1014:189-198
3. Gardner D (2007) Multiple endocrine neoplasia. In: Gardner D (ed) Greenspan's basic and clinical endocrinology, D.a. S. McGraw-Hill: New York
4. Langer P (2002) Adrenal involvement in multiple endocrine neoplasia type 1. World J Surg 26(8):891-896
5. Waldmann J (2007) Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening. Langenbecks Arch Surg 392(4):437-443
6. Skogseid B (1992) Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 75(1):76-81
7. Skogseid B (1995) Adrenal lesion in multiple endocrine neoplasia type 1. Surgery 118(6):1077-1082
8. Wermer P (1954) Genetic aspects of adenomatosis of endocrine glands. Am J Med 16(3):363-371
9. Fraumeni JF Jr, Miller RW (1967) Adrenocortical neoplasms with hemihypertrophy, brain tumors, and other disorders. J Pediatr 70(1):129-138
10. Li FP Fraumeni JF Jr (1969) Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med 71(4):747-752
11. Birch JM (1994) Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 54(5):1298-1304
12. Chompret A (2001) Sensitivity and predictive value of criteria for p53 germline mutation screening. J Med Genet 38(1):43-47
13. Chompret A (2000) P53 germline mutations in childhood cancers and cancer risk for carrier individuals. Br J Cancer 82(12):1932-1937
14. Eeles RA (1995) Germline mutations in the TP53 gene. Cancer Surv 25:101-124
15. Gonzalez KD (2009) Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations. J Clin Oncol 27(8):1250-1256
16. Li FP (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res 48(18):5358-5362
17. Lapunzina P (2005) Risk of tumorigenesis in overgrowth syndromes: a comprehensive review. Am J Med Genet C Semin Med Genet 137 C (1): 53-71
18. Hoyme HE (1998) Isolated hemihyperplasia (hemihypertrophy): report of a prospective multicenter study of the incidence of neoplasia and review. Am J Med Genet 79(4):274-278
19. Olivier M (2003) Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res 63(20):6643-6650
20. Tan TY, Amor DJ (2006) Tumour surveillance in Beckwith-Wiedemann syndrome and hemihyperplasia: a critical review of the evidence and suggested guidelines for local practice. J Paediatr Child Health, 2006. 42(9):486-490
21. Sorensen SA et al (1986) Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med 314(16):1010-1015
22. Wagner AS et al (2005) Pediatric adrenal cortical carcinoma: brain metastases and relationship to NF-1, case reports and review of the literature. J Neurooncol 75(2):127-133
23. Marshall WH et al (1967) Gardner's syndrome with adrenal carcinoma. Australas Ann Med 16(3):242-244
24. Painter TA, Jagelman DG (1985), Adrenal adenomas and adrenal carcinomas in association with hereditary adenomatosis of the colon and rectum. Cancer 55(9):2001-2004
25. Seki M (1992) Loss of normal allele of the APC gene in an adrenocortical carcinoma from a patient with familial adenomatous polyposis. Hum Genet 89(3):298-300
26. Traill Z et al (1995) Adrenal carcinoma in a patient with Gardner's syndrome: imaging findings. AJR Am J Roentgenol 165(6):1460-1461
27. Wakatsuki S (1998) Adrenocortical tumor in a patient with familial adenomatous polyposis: a case associated with a complete inactivating mutation of the APC gene and unusual histological features. Hum Pathol 29(3):302-306
28. Broaddus RR (2004) Unusual tumors associated with the hereditary nonpolyposis colorectal cancer syndrome. Mod Pathol 17(8):981-989
29. Berends MJ (2000) Adrenocortical adenocarcinoma in an MSH2 carrier: coincidence or causal relation? Hum Pathol 31(12):1522-1527
30. Takazawa R (2004) Unusual double primary neoplasia: adrenocortical and ureteral carcinomas in Werner syndrome. Urol Int 72(2):168-170
31. Varan A (2000) Adrenocortical carcinoma associated with adrenogenital syndrome in a child. Med Pediatr Oncol 35(1):88-90
32. Beckwith J (1963) Extreme cytomegaly of the adrenal fetal cortex, omphalocele, hyperplasia of kidneys and pancreas, and Leydig-cell hyperplasia: Another syndrome? Western Society for Pediatric Research, Los Angeles, CA
33. Beckwith JB (1955) Vignettes from the history of overgrowth and related syndromes. Am J Med Genet 79(4):238-248
34. Beatty EC Jr, Hawes CR (1955) Cytomegaly of the adrenal gland. AMA Am J Dis Child 89(4):463-467
35. Wiedemann H (1983) Tumours and Hemihypertrophy associated with Wiedemann-Beckwith syndrome. Eur J Pediatr 141:129
36. DeBaun MR (2002) Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am J Hum Genet 70(3):604-611
37. Figueiredo BC (2006) Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation. J Med Genet 43(1):91-96
38. Weksberg R et al (2005) Beckwith-Wiedemann syndrome. Am J Med Genet C Semin Med Genet 137 C (1): 12-23
39. Giordano TJ (2009) Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clin Cancer Res 15(2):668-676
40. Giordano TJ (2003) Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. Am J Pathol 162(2):521-531
41. Malkin D (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250(4985):1233-1238
42. Zambetti GP (2007) The p53 mutation "gradient effect" and its clinical implications. J Cell Physiol 213(2):370-373
43. Bell DW (1999) Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 286(5449):2528-2531
44. Barzon L (2001) Molecular analysis of CDKN1C and TP53 in sporadic adrenal tumors. Eur J Endocrinol 145(2):207-212
45. Reincke M (1994) p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies. J Clin Endocrinol Metab 78(3):790-794
46. Reincke M (1996) p53 mutations in adrenal tumors: Caucasian patients do not show the exon 4 "hot spot" found in Taiwan. J Clin Endocrinol Metab 81(10):3636-3638
47. Gardner EJ (1951) A genetic and clinical study of intestinal polyposis, a predisposing factor for carcinoma of the colon and rectum. Am J Hum Genet 3(2):167-176
48. Turcot J et al (1959) Malignant tumors of the central nervous system associated with familial polyposis of the colon: report of two cases. Dis Colon Rectum 2:465-468
49. Vasen HF (2008) Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 57(5):704-713
50. Marchesa P (1997) Adrenal masses in patients with familial adenomatous polyposis. Dis Colon Rectum 40(9):1023-1028
51. Smith TG (2000) Adrenal masses are associated with familial adenomatous polyposis. Dis Colon Rectum 43(12):1739-1742
52. Alexander GL et al (2000) Primary aldosteronism in a patient with familial adenomatous polyposis. Mayo Clin Proc 75(6):636-637
53. Beuschlein F (2000) Cortisol producing adrenal adenoma - a new manifestation of Gardner's syndrome. Endocr Res 26(4):783-790
54. Arvanitis ML (1990) Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 33(8):639-642
55. Blaker H (2004) Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli. Genes Chromosomes Cancer 41(2):93-98
56. Hosogi H (2009) Biallelic APC inactivation was responsible for functional adrenocortical adenoma in familial adenomatous polyposis with novel germline mutation of the apc gene: report of a case. Jpn J Clin Oncol 39(12):837-846
57. Offit K (1998) Clinical cancer genetics. 1st ed. 1998, New York: Wiley-Liss. 125-148
58. Tissier F (2005) Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Res 65(17):7622-7627
59. Schussheim DH (2001) Multiple endocrine neoplasia type 1: new clinical and basic findings. Trends Endocrinol Metab 12(4):173-178
60. Chandrasekharappa SC (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276(5311):404-407
61. Crabtree JS (2001) A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci U S A 98(3):1118-1123
62. Gibril F (2004) Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature. Medicine (Baltimore) 83(1):43-83
63. Beckers A (1992) Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type 1(MEN1): loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN1 locus. J Clin Endocrinol Metab 75(2):564-570
64. Trump D (1996) Clinical studies of multiple endocrine neoplasia type 1(MEN1). Qjm 89(9):653-669
65. Lindor NM (2008) Concise handbook of familial cancer susceptibility syndromes - second edition. J Natl Cancer Inst Monogr, 2008(38):1-93
66. Schulte KM (2000) Complete sequencing and messenger ribonucleic acid expression analysis of the MEN I gene in adrenal cancer. J Clin Endocrinol Metab 85(1):441-448
67. Schulte KM (1999) MEN I gene mutations in sporadic adrenal adenomas. Hum Genet 105(6):603-610
68. Vortmeyer AO (1999) Multiple endocrine neoplasia type 1: atypical presentation, clinical course, and genetic analysis of multiple tumors. Mod Pathol 12(9):919-924
69. Gortz B (1999) MEN1 gene mutation analysis of sporadic adrenocortical lesions. Int J Cancer 80(3):373-379
70. Karagiannis A (2007) Pheochromocytoma: an update on genetics and management. Endocr Relat Cancer 14(4):935-956
71. Bausch B (2006) Comprehensive mutation scanning of NF1 in apparently sporadic cases of pheochromocytoma. J Clin Endocrinol Metab 91(9):3478-3481
72. Rasmussen SA, Friedman JM (2000) NF1 gene and neurofibromatosis 1. Am J Epidemiol 151(1):33-40
73. Brandi ML (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86(12):5658-5671
74. Elliott M (1994) Clinical features and natural history of Beckwith-Wiedemann syndrome: presentation of 74 new cases. Clin Genet 46(2):168-174
75. Ferner RE (2007) Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 44(2):81-88
76. Clericuzio CL, Martin RA (2009) Diagnostic criteria and tumor screening for individuals with isolated hemihyperplasia. Genet Med 11(3):220-222
77. Ferrandez A (2006) An evidence-based, multidisciplinary approach to the clinical considerations, management, and surveillance of adrenal lesions in familial adenomatous polyposis: report of three cases. Dis Colon Rectum 49(11):1781-1790
78. Nielsen M (2007) Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis. Clin Genet 71(5):427-433
79. Gardner EJ, Richards RC (1953) Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. Am J Hum Genet 5(2):139-147
80. Fienman NL, Yakovac WC (1970) Neurofibromatosis in childhood. J Pediatr 76(3):339-346.